Cargando…

Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya

BACKGROUND: Few studies have investigated risk factor heterogeneity by molecular subtypes in indigenous African populations where prevalence of traditional breast cancer (BC) risk factors, genetic background, and environmental exposures show marked differences compared to European ancestry populatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayed, Shahin, Fan, Shaoqi, Moloo, Zahir, Wasike, Ronald, Bird, Peter, Saleh, Mansoor, Shaikh, Asim Jamal, Figueroa, Jonine D., Naidoo, Richard, Makokha, Francis W., Gardner, Kevin, Oigara, Raymond, Njoroge, Faith Wambui, Magangane, Pumza, Mutebi, Miriam, Chauhan, Rajendra, Mwanzi, Sitna, Govender, Dhirendra, Yang, Xiaohong R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235821/
https://www.ncbi.nlm.nih.gov/pubmed/34174935
http://dx.doi.org/10.1186/s13058-021-01446-3
_version_ 1783714408003796992
author Sayed, Shahin
Fan, Shaoqi
Moloo, Zahir
Wasike, Ronald
Bird, Peter
Saleh, Mansoor
Shaikh, Asim Jamal
Figueroa, Jonine D.
Naidoo, Richard
Makokha, Francis W.
Gardner, Kevin
Oigara, Raymond
Njoroge, Faith Wambui
Magangane, Pumza
Mutebi, Miriam
Chauhan, Rajendra
Mwanzi, Sitna
Govender, Dhirendra
Yang, Xiaohong R.
author_facet Sayed, Shahin
Fan, Shaoqi
Moloo, Zahir
Wasike, Ronald
Bird, Peter
Saleh, Mansoor
Shaikh, Asim Jamal
Figueroa, Jonine D.
Naidoo, Richard
Makokha, Francis W.
Gardner, Kevin
Oigara, Raymond
Njoroge, Faith Wambui
Magangane, Pumza
Mutebi, Miriam
Chauhan, Rajendra
Mwanzi, Sitna
Govender, Dhirendra
Yang, Xiaohong R.
author_sort Sayed, Shahin
collection PubMed
description BACKGROUND: Few studies have investigated risk factor heterogeneity by molecular subtypes in indigenous African populations where prevalence of traditional breast cancer (BC) risk factors, genetic background, and environmental exposures show marked differences compared to European ancestry populations. METHODS: We conducted a case-only analysis of 838 pathologically confirmed BC cases recruited from 5 groups of public, faith-based, and private institutions across Kenya between March 2012 to May 2015. Centralized pathology review and immunohistochemistry (IHC) for key markers (ER, PR, HER2, EGFR, CK5-6, and Ki67) was performed to define subtypes. Risk factor data was collected at time of diagnosis through a questionnaire. Multivariable polytomous logistic regression models were used to determine associations between BC risk factors and tumor molecular subtypes, adjusted for clinical characteristics and risk factors. RESULTS: The median age at menarche and first pregnancy were 14 and 21 years, median number of children was 3, and breastfeeding duration was 62 months per child. Distribution of molecular subtypes for luminal A, luminal B, HER2-enriched, and triple negative (TN) breast cancers was 34.8%, 35.8%, 10.7%, and 18.6%, respectively. After adjusting for covariates, compared to patients with ER-positive tumors, ER-negative patients were more likely to have higher parity (OR = 2.03, 95% CI = (1.11, 3.72), p = 0.021, comparing ≥ 5 to ≤ 2 children). Compared to patients with luminal A tumors, luminal B patients were more likely to have lower parity (OR = 0.45, 95% CI = 0.23, 0.87, p = 0.018, comparing ≥ 5 to ≤ 2 children); HER2-enriched patients were less likely to be obese (OR = 0.36, 95% CI = 0.16, 0.81, p = 0.013) or older age at menopause (OR = 0.38, 95% CI = 0.15, 0.997, p = 0.049). Body mass index (BMI), either overall or by menopausal status, did not vary significantly by ER status. Overall, cumulative or average breastfeeding duration did not vary significantly across subtypes. CONCLUSIONS: In Kenya, we found associations between parity-related risk factors and ER status consistent with observations in European ancestry populations, but differing associations with BMI and breastfeeding. Inclusion of diverse populations in cancer etiology studies is needed to develop population and subtype-specific risk prediction/prevention strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13058-021-01446-3.
format Online
Article
Text
id pubmed-8235821
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82358212021-06-28 Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya Sayed, Shahin Fan, Shaoqi Moloo, Zahir Wasike, Ronald Bird, Peter Saleh, Mansoor Shaikh, Asim Jamal Figueroa, Jonine D. Naidoo, Richard Makokha, Francis W. Gardner, Kevin Oigara, Raymond Njoroge, Faith Wambui Magangane, Pumza Mutebi, Miriam Chauhan, Rajendra Mwanzi, Sitna Govender, Dhirendra Yang, Xiaohong R. Breast Cancer Res Research Article BACKGROUND: Few studies have investigated risk factor heterogeneity by molecular subtypes in indigenous African populations where prevalence of traditional breast cancer (BC) risk factors, genetic background, and environmental exposures show marked differences compared to European ancestry populations. METHODS: We conducted a case-only analysis of 838 pathologically confirmed BC cases recruited from 5 groups of public, faith-based, and private institutions across Kenya between March 2012 to May 2015. Centralized pathology review and immunohistochemistry (IHC) for key markers (ER, PR, HER2, EGFR, CK5-6, and Ki67) was performed to define subtypes. Risk factor data was collected at time of diagnosis through a questionnaire. Multivariable polytomous logistic regression models were used to determine associations between BC risk factors and tumor molecular subtypes, adjusted for clinical characteristics and risk factors. RESULTS: The median age at menarche and first pregnancy were 14 and 21 years, median number of children was 3, and breastfeeding duration was 62 months per child. Distribution of molecular subtypes for luminal A, luminal B, HER2-enriched, and triple negative (TN) breast cancers was 34.8%, 35.8%, 10.7%, and 18.6%, respectively. After adjusting for covariates, compared to patients with ER-positive tumors, ER-negative patients were more likely to have higher parity (OR = 2.03, 95% CI = (1.11, 3.72), p = 0.021, comparing ≥ 5 to ≤ 2 children). Compared to patients with luminal A tumors, luminal B patients were more likely to have lower parity (OR = 0.45, 95% CI = 0.23, 0.87, p = 0.018, comparing ≥ 5 to ≤ 2 children); HER2-enriched patients were less likely to be obese (OR = 0.36, 95% CI = 0.16, 0.81, p = 0.013) or older age at menopause (OR = 0.38, 95% CI = 0.15, 0.997, p = 0.049). Body mass index (BMI), either overall or by menopausal status, did not vary significantly by ER status. Overall, cumulative or average breastfeeding duration did not vary significantly across subtypes. CONCLUSIONS: In Kenya, we found associations between parity-related risk factors and ER status consistent with observations in European ancestry populations, but differing associations with BMI and breastfeeding. Inclusion of diverse populations in cancer etiology studies is needed to develop population and subtype-specific risk prediction/prevention strategies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13058-021-01446-3. BioMed Central 2021-06-26 2021 /pmc/articles/PMC8235821/ /pubmed/34174935 http://dx.doi.org/10.1186/s13058-021-01446-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Sayed, Shahin
Fan, Shaoqi
Moloo, Zahir
Wasike, Ronald
Bird, Peter
Saleh, Mansoor
Shaikh, Asim Jamal
Figueroa, Jonine D.
Naidoo, Richard
Makokha, Francis W.
Gardner, Kevin
Oigara, Raymond
Njoroge, Faith Wambui
Magangane, Pumza
Mutebi, Miriam
Chauhan, Rajendra
Mwanzi, Sitna
Govender, Dhirendra
Yang, Xiaohong R.
Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya
title Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya
title_full Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya
title_fullStr Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya
title_full_unstemmed Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya
title_short Breast cancer risk factors in relation to molecular subtypes in breast cancer patients from Kenya
title_sort breast cancer risk factors in relation to molecular subtypes in breast cancer patients from kenya
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235821/
https://www.ncbi.nlm.nih.gov/pubmed/34174935
http://dx.doi.org/10.1186/s13058-021-01446-3
work_keys_str_mv AT sayedshahin breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya
AT fanshaoqi breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya
AT moloozahir breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya
AT wasikeronald breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya
AT birdpeter breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya
AT salehmansoor breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya
AT shaikhasimjamal breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya
AT figueroajonined breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya
AT naidoorichard breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya
AT makokhafrancisw breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya
AT gardnerkevin breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya
AT oigararaymond breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya
AT njorogefaithwambui breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya
AT maganganepumza breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya
AT mutebimiriam breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya
AT chauhanrajendra breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya
AT mwanzisitna breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya
AT govenderdhirendra breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya
AT yangxiaohongr breastcancerriskfactorsinrelationtomolecularsubtypesinbreastcancerpatientsfromkenya